Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Korean Journal of Gynecologic Oncology and Colposcopy
>
1999
>
10
Volume:
10
1. HER-2/neu Oncogene Amplification; A Factor for Predicting Response of Platinum-based Combination Chemotherapy in Ovarian Cancers.
Page:130—137
2. Expression of p73 in Null-p53 SKOV3 Ovarian Cancer Cell Line.
Page:122—129
3. Clinico-Pathologic Study on Borderline Epithelial Tumors of the Ovary.
Page:115—121
4. A Case of Miillerian Adenosarcoma of the Uterus with Squamous Cell Carcinoma of the Uterine Cervix.
Page:200—204
5. A Case of Cellular Schwannoma of the Retroperitoneum.
Page:194—199
6. A case of Primary Serous Papillary Carcinoma of the Peritoneum..
Page:190—193
7. 3 Cases of Synchronous Primary Carcinomas.
Page:183—189
8. Predictability of the Survival using Prognostic Index (PI) of Patients with Epithelial Ovarian Cancer.
Page:173—182
9. Neoadjuvant Chemotherapy for the Bulky-endophytic or Barrel-shaped Cervix.
Page:164—172
10. Accuracy of Cervical Pap Smear.
Page:156—163
11. Phase III Study of Pirarubicin / Cyclophosphamide / CDDP(CTP) vs. Doxorubicin / Cyclophosphamide / CDDP(CAP) Combination Chemotherapy in Advanced Epithelial Ovarian Cancer.
Page:148—155
12. Association Between Apoptosis and Development of the Cervical Neoplasia.
Page:138—147
13. A Case of Benign Ovarian Steroid Cell Tumor with Huge Ascites and Elevated Serum CA125.
Page:300—305
14. A Case of Malignant Mixed Mullerian Tumor of Ovary.
Page:295—299
15. Clinicopathologic Analysis of Four Cases of Primary Ovarian and Parovarian Transitional Cell Carcinoma.
Page:287—294
16. Mapping of Multiple Genetic Alteration Sites of Cervical Carcinomas by Comparative Genomic Hybridization.
Page:280—286
17. Expression of bcl-2 and p53 Protein in Invasive Cervical Cancer.
Page:272—279
18. Prediction of the Diagnosis of Adnexal Masses According to the Ultrasonographic Morphologic Scoring System and Doppler Velocity Wave Form.
Page:264—271
19. Serum Levels of ICAM-1(In tercelluar Adhesion Molecule-1) in Invasive Cervical Cancer.
Page:258—263
20. Pelvic Drainage Following Radical Hysterectomy with Pelvic Lymphadenectomy for Cervical Cancer: Is it Necessary? .
Page:251—257
21. A Clinical and Pathological Observation of Microinvasive Carcinoma of Uterine Cervix.
Page:242—250
22. Effect of Gl Cyclins Expression on Clinical Prognostic Parameters in Cervical Carcinoma.
Page:233—241
23. The Significance of High-Hisk HPV Infection and Resection Margin Status in CIN Treated by LEEP.
Page:224—232
24. Expression of Fragile Histidine Triad (FHIT) Gene Product in the Uterine Cervical Carcinoma.
Page:217—223
25. The Mechanisms of the Antiproliferative Effect by Interferon- a in Cervical Cancer Cell Lines.
Page:75—87
26. The Diagnosis and Treatment in 46 Cases with Microinvasive Carcinoma of the Cervix Uteri.
Page:67—74
27. Apoptosis and Cell Cycle Arrest with EGF, TGF- a and TGF- 8 in Cervical Cancer Cell Lines .
Page:58—66
28. Analysis of the Transmission Route of Human Papillomavirus in Heterosexual Couples.
Page:47—57
29. Phase II Study of FAC(5-FU/Interferon- a/CBDCA) as Neoadjuvant Chemotherapy in Patients with Locally Advanced and/or Bulky.
Page:39—46
30. Detection of Human Papilloma Virus(HPV) in the Patients with ASCUS or LGSIL of the Cervical Cytology.
Page:32—38
31. Telomerase Activity of Endometrium Related to the Effects of the Sex Steroid Hormone and Endometrial Cancer.
Page:24—31
32. The Efficacy of Cervicography Combined with Pap Smear in Cervical Cancer Screening.
Page:13—23
33. The Clinical Significance of Cervical ASCUS(Atypical Squamous Cells of Undetermined Significance) and Its Relationship with Eating Habits in Asymptommatic Women.
Page:3—12
34. One Case of Primary Extragonadal Germ Cell Tumor of Retroperitoneal Origin.
Page:406—410
35. Two Cases of Malignant Mixed Mullerian Tumor (MMMT) of the Ovary.
Page:401—405
36. A Case of Primary Leiomyosarcoma of the Uterine Cervix.
Page:397—400
37. Clinicopathological Analysis of Malignant Germ Cell Tumors of Ovary.
Page:388—396
38. Clinical value of Serum Vascular Endothelial Growth Factor (VEGF) in Ovarian Cancer Patients .
Page:380—387
39. The Clinical Analysis of Endometrial Cancer by Surgical Staging.
Page:368—379
40. A Clinical Study on Gestational Trophoblastic Disease.
Page:358—367
41. Predictive Value of Clinical Examination, Computed Tomography and Magnetic Resonance Imaging in the Clinical Staging of the Cervical Carcinoma.
Page:350—357
42. Flow Cytometric Analysis of DNA patterns in Carcinoma of the Uterine Cervix.
Page:342—349
43. The Programming of Chemotherapy Order System in Gynecology Oncology.
Page:331—341
44. The Evaluation of SCC (squamous cell carcinoma antigen) Level as a Tumor Marker in Patient with Squamous Cell Carcinoma of the Cervix.
Page:324—330
45. Association Between Infection of Human Papillomavirus and Decreased Expression of Cyclin DI in Cervical Neoplasia.
Page:315—323
46. An Unsuspected Primary Tubal Carcinoma During Operative Laparoscopy.
Page:103—107
47. A Case of Juvenile Cystic Granulosa Cell Tumor of the Ovary.
Page:96—102
48. Small Cell Neuroendocrine Carcinoma of the Uterine Cervix.
Page:88—95